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Abstract
Benzene is an occupational toxicant and an environmental pollutant that potentially causes hematotoxicity and leukemia in
exposed populations. Epidemiological studies suggest an association between an increased incidence of childhood
leukemia and benzene exposure during the early stages of pregnancy. However, experimental evidence supporting the
association is lacking at the present time. It is believed that benzene and its metabolites target hematopoietic stem cells
(HSCs) to cause toxicity and cancer in the hematopoietic system. In the current study, we compared the effects of
hydroquinone (HQ), a major metabolite of benzene in humans and animals, on mouse embryonic yolk sac hematopoietic
stem cells (YS-HSCs) and adult bone marrow hematopoietic stem cells (BM-HSCs). YS-HSCs and BM-HSCs were isolated and
enriched, and were exposed to HQ at increasing concentrations. HQ reduced the proliferation and the differentiation and
colony formation, but increased the apoptosis of both YS-HSCs and BM-HSCs. However, the cytotoxic and apoptotic effects
of HQ were more apparent and reduction of colony formation by HQ was more severe in YS-HSCs than in BM-HSCs.
Differences in gene expression profiles were observed in HQ-treated YS-HSCs and BM-HSCs. Cyp4f18 was induced by HQ
both in YS-HSCs and BM-HSCs, whereas DNA-PKcs was induced in BM-HSCs only. The results revealed differential effects of
benzene metabolites on embryonic and adult HSCs. The study established an experimental system for comparison of the
hematopoietic toxicity and leukemogenicity of benzene and metabolites during mouse embryonic development and
adulthood.
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Introduction
Benzene is the simplest aromatic compound and is widely used
in industrial and chemical manufacturing. Epidemiological studies
and case reports have suggested a close relationship between
occupational exposure to benzene and the occurrence of
hematotoxicity and various types of leukemia [1,2]. High-levels
of exposure to benzene results in an increased risk of aplastic
anemia, pancytopenia, acute myeloid leukemia, and other forms of
leukemia in adults [3–6].
Childhood leukemia is a major form of cancer in children that
develops in the hematopoietic system and is characterized with the
production of large amounts of immature white blood cells. The
incidence rates of childhood leukemia have been on the rise on an
annual basis in recent years. The number of children suffering
from leukemia accounts for one third of all children with tumor.
Acute lymphoblastic leukemia (ALL) is the most common form of
childhood cancer worldwide. The mean annual leukemia
incidence per million children is 16.4 in low-income countries,
36.5 in middle-income countries, and 40.9 in high-income
countries [7]. The cause and oncogenic development of childhood
leukemia and why the incidence increases is largely unknown at
the present time.
Although the past research on benzene-induced leukemia has
been primarily focused on occupational benzene poisoning and
oncogenesis, several recent epidemiological studies have indicated
that increased exposure to benzene from the environment is
potentially a major cause of childhood leukemia [7–10]. For
example, Freedman et al. have identified an association between
elevated risk of childhood ALL and maternal exposure to interior
house painting, which is associated increased exposure of benzene,
during the 12 months before the birth of their children [11].
Moreover, several leukemia-associated translocations of DNA
were found in embryos. Therefore, it is rational to hypothesize that
childhood leukemia may have occurred during the fetal stage of
development [12–16]. Nonetheless, there is no consensus on
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whether childhood leukemia is a primary disease, or a disease
caused by early exposure to environmental risk factors before or
after birth. Overall, these studies suggest that prenatal exposure to
benzene may increase hematopoietic system DNA instability,
genetic susceptibility to cancer, and exposure to leukemogenic
factors in early pregnancy and, thereby, contribute to the
increased incidence of childhood leukemia [17]. In these scenarios,
benzene or benzene metabolites would have a significant effect on
the embryonic hematopoietic system. However, few studies have
examined the effects of benzene on embryonic hematopoiesis and
childhood leukemia experimentally.
The hematopoietic stem cells (HSC) are responsible for the
development of all blood cells. During the development of the
embryonic hematopoietic system, placenta, yolk sac and the pre-
fusion allantois are recognized as the hematopoietic organs in
mammals [18–21]. The yolk sac is the major site of embryonic
erythropoiesis. Because it is impossible to analyze hematopoietic
functions in human fetuses, much of the knowledge on embryonic
hematopoiesis comes from studies on mouse embryos [2]. It has
been found that the murine embryonic yolk sacs contain the most
primitive hematopoietic, pluripotent stem cells——the yolk sac
hematopoietic stem cells (YS-HSC) [22]. It is noteworthy to point
out that a recent study showed that major HSC in adults are
possibly derived from yolk sac precursors [23]. These findings
suggest that the murine YS-HSC cells are suitable targets for
investigating the toxicity of benzene metabolites on the embryonic
hematopoietic system.
Little is known about the mechanism of benzene hematotoxicity
and carcinogenicity. We have previously found that the expres-
sions of CYP4F3A and DNA-PKcs were elevated in workers
diagnosed with benzene poisoning by microarray analysis of
peripheral mononuclear blood cells. In K562 and HL-60 cells,
CYP4F3A and DNA-PKcs were shown to be induced by benzene
metabolites at both protein and mRNA levels [24–27]. CYP4f3A
encodes the leukotriene B4 v-hydroxylase in human polymorpho-
nuclear leukocytes. The CYP4f18 is the murine ortholog of the
human CYP4f3 [28]. DNA-PKcs is the catalytic subunit of the
nuclear DNA-dependent serine/threonine protein kinase that
plays a critical role in the non-homologous end joining (NHEJ)
pathway of DNA double strand (DSB) break repair [29]. Whether
CYP4F18 and DNA-PKcs can be induced by benzene and
metabolites in murine adult and embryonic hematopoietic stem
cells remains unknown.
The goal of the present study was to investigate the toxicity of
hydroquinone (HQ), a major metabolite of benzene in both
humans and animals, on YS-HSC in mice and to determine
whether YS-HSC are more susceptible to HQ effects than BM-
HSC as a possible contributing mechanism to childhood leukemia.
We measured the effects of HQ on the colony formation, cell
proliferation and apoptosis of the HSCs. Expression of the
Cyp4f18 and DNA-PKcs were measured to explore the effect of
HQ at the level of gene expression and protein.
Materials and Methods
Ethics Statement
All experiments were approved by the Institutional Animal Care
and Use Committee of Wuhan University (No. 10061), and the
animal procedures were performed in accordance with institu-
tional and national guidelines. All surgery was performed under
anesthesia with ketamine and lidocaine, and all efforts were made
to minimize suffering.
Isolation and proliferation of hematopoietic stem cells
from murine embryonic yolk sac and adult bone marrow
Special pathogen free (SPF) Kunming mice were purchased
from the Central Animal Facility of Wuhan University. Kunming
mice were original from Swiss mice and were brought to
Kunming, China, from the Indian Haffkine Institute in 1944.
This mice line has been widely utilized in pharmacological,
toxicological, medicinal and biological research and testing
because of its’ high disease resistance, good adaptive capacity,
high breeding coefficient and good survival rate.
For isolation of BM-HSC, 8–10 weeks old Kunming male mice
were used. Murine bone marrow cells from femur and tibias were
collected by flushing the shaft with a buffer using a syringe and a
26G needle. The cells were filtered through a 40 mm nylon mesh
(BD Biosciences). The cells were first depleted of lineage positive
(Lin+) cells using magnetic columns and then was positively
selected using anti-Sca1 antibodies and anti-murine CD117
antibodies conjugated to mini-magnetic beads (Miltenyi Biotec,
Inc., Auburn, CA, http://www.miltenyibiotec.com) according to
the manufacturer’s instructions. Up to 4.56106 of lineage2
CD117+ Sca1+ cells can be isolated from two murine cell
suspensions.
For isolation of YS-HSC, the uterine horns were collected from
a pregnant female on 8–10 days post conception. The endometrial
tissues were removed from around each embryo conceptus under
the microscope. The placental tissue was removed to reveal the
embryo encased in the yolk sac by using the forceps to cut the
embryo-encased yolk sac away from the placenta at their
junctures. The yolk sac containing vitelline arteries and a portion
of the umbilical cord can be gently teased away from the embryo
and set aside on ice for dissociation. The yolk sacs were placed in
separate tubes. The tissues were pelleted by a brief spin and were
resuspended in 0.25% collagenase in PBS with 20% FBS, with
enough volume to adequately cover the tissues. The tissues were
incubated at 37uC for 40 min for yolk sacs. At the end of the
incubation, the tissues were dissociated into single cell suspensions
by gently pipetting up and down. The cells were filtered through a
40 mm nylon mesh. The cells was first depleted of lineage positive
(Lin+) cells using magnetic columns and was then positively
selected by using anti-murine CD117 antibodies conjugated to
mini-magnetic beads (Miltenyi Biotec, Inc., Auburn, CA, http://
www.miltenyibiotec.com). Up to 3.26106 of lineage2 CD117+
cells were isolated from eight yolk sac cell suspensions.
Isolated HSC cells were cultured at 37uC with 5% humidified
CO2 in the StemSpan
TM Serum-Free Expansion Medium (Stem
Cell Technologies, Inc, Vancouver, BC, Canada) in polystyrene 6-
well plates with the addition of cytokines SCF (100 ng/ml), IL-3
(20 ng/ml), and Flt-3 (100 ng/ml) (Peprotech USA).
Histology and immunohistochemistry
Paraformaldehyde fixed embryonic yolk sac tissues were
embedded in paraffin and sectioned at 5 mm thickness using
standard procedures performed at a Pathology Laboratory,
Wuhan University School of Medicine. Samples were embedded
in paraffin and at least two sections per tissue were prepared and
stained with hematoxylin and eosin. After dewaxing and
hydration, the paraffin sections were rinsed three times with
PBS (0.01 M, pH 7.5) each for 3 min. Antigen retrieval was
performed according to the requirements of each antibody. Each
slide was incubated for 10 min at room temperature in a 50 ml
peroxidase blocking solution (UltraSensitiveTMSP Kit, Maixin.Bio)
to block endogenous peroxidase activities. The slides were then
washed three times with PBS and were incubated for 10 min in
50 ml of a normal non-immune serum (UltraSensitiveTMSP Kit,
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Maixin.Bio) at room temperature. Staining for CD41 was
performed using rabbit polyclonal antibodies (Biolegend USA)
incubated at 4uC overnight. After washing in PBS, the slides were
incubated in 1:150 dilution of appropriate secondary antibodies
conjugated to biotin rabbit anti-rat antibodies (Boster, Wuhan,
China), followed by incubation with Stretavidin-Peroxidase
(UltraSensitiveTMSP Kit, Maixin.Bio) for 10 min. The slides were
stained with DAB and processed for mounting with neutral gums.
Immunophenotyping
After separation of yolk sacs using the CD117 MicroBeads, the
cells were washed and fluorescently stained with mouse CD117
antibodies conjugated with PE (#130-0991-730) by incubation for
10 min in the dark on ice. The cells were washed and resuspended
in PBS containing 0.5% bovine serum albumin (BSA). Flow
cytometric analysis was carried out on a flow cytometer (Epics
Altra II, Beckman, USA).
Colony-forming unit (CFU) assay
A cell suspension of 56104 cells/mL was used. About 0.3 mL of
cells was added to 3 ml of the MethoCultH Medium containing 0,
1.25, 2.5 and 5.0 mM of HQ supplemented with SCF, IL-3, IL-6,
and Epo (Stem Cell Technologies, Inc, Vancouver, BC, Canada)
for duplicate cultures. The tubes were votexed to ensure all cells
and components are thoroughly mixed. The tubes were allowed to
stand for 5 min to allow bubbles to dissipate. The medium was
dispensed into culture dishes, 1.1 ml per 35 mm dish. A needle
was placed below the surface of the solution to gently depress the
plunger and expel the medium completely until no air space is
visible. Two dishes were placed into a 100 mm petri dish. A third,
uncovered 35 mm dish containing 3 ml of sterile water was placed
in to maintain humidity and minimize contamination during
culture and handling. The dishes were cultured in an incubator
maintained at 37uC with 5% CO2 and 95% humidity.
Cytotoxicity assays
Cell viability and cell count were evaluated by using the CCK-8
and Trypan blue exclusion assays after 24 h of HQ exposure. For
the CCK-8 assay, 100 ml of cell suspension (5,000 cells/well) were
seeded in a 96-well plate that was preincubated for 24 h at 37uC,
5% CO2. Ten ml of various concentrations of substances to be
tested was added to the plates. The plate was incubated for 24 h in
the incubator. Ten ml CCK-8 was added into each well and
incubation was continued for another 1 h. Absorbance was
measured at 450 nm using a microplate reader. For the Trypan
blue exclusion assay, about 16106 cells were seeded onto a 60 mm
culture dish and then, were treated with HQ. Cells were scraped,
pelleted and resuspended in PBS. Equal volumes of cell suspension
and 0.4% Trypan blue were mixed. Viable cells were counted
under a microscope and cell viability was expressed as the viable
cell numbers/total cell numbers multiplied by 100.
Apoptosis analysis
The Annexin V/Propidium Iodide (PI) kit (KeyGEN Biotech,
Nanjing, China) were used to evaluate apoptosis by flow cytometer
according to the manufacturer’s protocol (Epics Altra II, Beckman,
USA) performed at Center for Medical Research at Wuhan
University School of Medicine. Briefly, cells were washed twice
with cold PBS and resuspended in 500 ml binding buffer, and were
then stained with 5 ml Annexin V-FITC and 10 ml PI. The cells
were incubated for 10 min at room temperature in the dark and
analyzed in a Beckman flow cytometer. Percent of cells
undergoing early apoptosis (Annexin V-positive and PI-negative)
and late apoptosis (Annexin V-positive and PI- positive) were
combined to derive the percentages of total apoptotic cells.
Quantitative real–time PCR
Total RNA was extracted using the TRIzol reagent (Invitrogen,
Carlsbad, CA). One mg of total RNA was reverse-transcribed to
complementary DNA using the All-in-One First Strand cDNA
Synthesis Kit (GeneCopoeia, USA). Quantitative real–time PCR
was performed on the ABI StepOne plus Real-Time PCR System,
using the All-in-One qPCR Mix (GeneCopoeia, USA). The PCR
amplification conditions were as follows: 95uC for 10 min (Initial
denaturation); 40 cycles of 95uC for 10 seconds (denaturation);
55uC for 20 seconds (annealing) and 72uC for 30 seconds
(extension). The relative expression of target genes was calculated
using the 22DDCt method. b-actin was used as an internal control.
The primers used were as follows: DNA-PKcs forward 59-
TGTCACAAGAGGAGAAAGTGGC-39 and reverse 59-TGTA-
CATTAGCACATAGGCTCC-39; CYP4f18 forward 59-
AGAGCCTGGTGCGAACCTT-39 and reverse 59-TGGAATA-
TACGGATGACTGG-39; b-actin forward 59-AA-
CAGTCCGCCTAGAAGCAC-39and reverse 59- CGTTGA-
CATCCGTAAAGACC-39.
Immunofluorescence
For the detection of c-H2AX, cells (1.2–1.56106/ml) were
seeded into 60 mm culture dishes and treated with HQ for 6 h.
Cells were washed once with PBS for 5 min, and then were
paraformaldehyde-fixed and blocked with BSA prior to incubation
with anti- cH2A.X (phospho S139) antibody (ab11174, abcam) for
45 min at 37uC. An Alexa-Fluor H 488 conjugated goat anti-rabbit
antibody (Jackson ImmunoResearch Laboratories, West Grove,
PA) was used as the secondary antibody at a dilution of 1:500 in
PBS incubated for 30 min at 37uC. Cells were washed with PBS
and were counterstained with 3 mg/ml PI (Sigma, MO) in PBS for
5 min. Fluorescence was detected under a confocal microscope.
Immunoblotting
Cells (3.0–3.56106/ml) were seeded into 60-mm culture dishes
and treated with HQ for 24 h. Cells were washed twice with ice-
cold PBS and then lysed in a lysis buffer (2 mM sodium
orthovanadate, 50 mM NaF, 20 mM HEPES, pH 7.5, 150 mM
NaCl, 1.5 mM MgCl2, 5 mM sodium pyrophosphate, 10%
glycerol, 0.2%Triton X-100, 5 mM EDTA, 1 mM PMSF,
10 mg/ml leupeptin, and 10 mg/ml aprotinin) on ice for 30 min.
Insoluble materials were pelleted at 14,0006g for 20 min at 4uC.
Whole-cell protein was mixed with the SDS sample buffer, and
was boiled for 5 min. Equal amounts of protein (30 mg) were
electrophoresed on 10% SDS/PAGE and were electroblotted onto
PVDF membranes and identified with anti-Cyp4f3 polyclonal
antibodies (Abnova, Taipei, Taiwan) (the antibody recognizes the
murine ortholog Cyp4F18 of human Cyp4F3 by immunoblotting),
anti-p53 polyclonal antibodies (ABclonal, USA) and anti-GAPDH
polyclonal antibodies (Bioworld Technology, USA). Secondary
goat anti-mouse IgG–HRP (Bioworld Technology, USA) or goat
anti-rabbit IgG–HRP (Bioworld Technology, USA) was used
according to the species of primary antibody. Chemiluminescence
was performed using SuperSignal West Dura (Pierce) and the
FluorChem 8900 visualization system (Alpha Innotech). The
relative density of detected signals was analyzed by using the image
analysis software (Image 1.56, NIH).
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Statistical analysis
SPSS 17.0 was used for data analysis. Data were expressed as
means 6 SDs. The statistical analysis was determined by one-way
analysis of variance (ANOVA) followed by Least Significant
Difference test (LSD) and Dunnett’s T3. Differences of total
colonies forming units between BM-HSC and YS-HSC in the
HQ = 1.25 mM groups were performed using independent two-
tailed t test. P,0.05 was considered statistically significant.
Results
Isolation of HSCs from murine yolk sacs
The HSCs in murine yolk sacs were identified by their
expression of CD41 and CD117 on the cell surface. CD41 is a
specific cell surface marker of nascent HSCs [30–32]. CD117 (c-
kit) has also been identified as a marker on HSCs [33,34]. Figure 1
shows the immunohistochemistry staining of CD41 positive
hematopoietic progenitor cells from murine yolk sacs. CD41-
expressing cells were found to be present in the E9 (embryonic day
9) murine yolk sacs. Expression of the hematopoietic stem cell
antigen maker CD117 on the surface of sorted yolk sac cells were
analyzed by flow cytometry. Figure 2 illustrates one typical
experiment from a total of three experiments. From murine yolk
sac cells containing about 19.3566.29% (n = 4) CD117+ cells, the
CD117 positive cells in the enriched fraction typically account for
up to 78.3869.34% (n = 4) (Fig. 2).
Effect of HQ on colony-forming units of YS-HSC and BM-
HSC
The colony sizes of CFU-GM and CFU-E/BFU-E and the total
CFU numbers decreased upon treatment with increasing concen-
trations of HQ in both BM-HSC and YS-HSC (Figure 3).
However, the decrease was markedly more apparent in YS-HSC
than BM-HSC. At 5.0 mM of HQ, there was no typical
erythrocyte colony formation in HQ-treated YS-HSC, but colony
formation in HQ-treated BM-HSC was still observed. Quantifi-
cation of CFUs expressed as percent of controls confirmed that
HQ reduced the CFUs in concentration-dependent manners in
both BM-HSC and YS-HSC; however, the reduction in YS-HSCs
was significantly faster as HQ concentration increases than BM-
HSC (Figure 3c and d). It is noteworthy to point out that no
significant differences were detected in the total CFU numbers of
BM-HSC between the 1.25 and 2.5 mM groups (Figure 3c and d).
These results indicated that HQ has significantly higher toxicity on
the differentiation and proliferation of embryonic HSC than adult
bone marrow HSCs.
Cytotoxicity of HQ on YS-HSC and BM-HSC
CCK-8 and trypan blue assays were conducted to determine the
cytotoxicity of HQ on HSCs. Cell viability was measured by
trypan blue exclusion under microscope after the cells were treated
with hydroquinone for 24 h. There was a negative correlation
between HQ concentrations and the cell survival rates both in
BM-HSC and YS-HSC (Figure 4a). However, in comparison with
the bone marrow HSCs, reduction in the viability of YS-HSC was
more obvious than that of BM-HSC. Similar results were obtained
by using the CCK-8 assay (Figure 4b). These findings indicate
that, within the HQ concentration range examined, the cytotox-
icity of HQ on YS-HSC was more noticeable than on BM-HSC.
HQ-Induced Apoptosis in BM-HSC and YS-HSC
Since differential cytotoxic effects were observed between BM-
HSC and YS-HSC following treatment with HQ, we evaluated
the level of apoptosis in the cells as a possible mechanism for the
observed differences. BM-HSC and YS-HSC were treated with
HQ at increasing concentrations. The percentages of cells
undergoing early apoptosis (annexin V positive and PI negative)
and late apoptosis (annexin V positive and PI positive) were
combined as the total apoptosis as described under Materials and
Methods. HQ increased apoptosis in BM-HSC cells at 1.25 and
2.5 mM concentrations slightly compared with the control
(Figure 5b). On the other hand, HQ induced large increases in
apoptosis at concentrations of 2.5, 5, and 10 mM in YS-HSC
(Figure 5a). The increases in YS-HSC were markedly more
apparent compared with those of BM-HSC treated with the same
concentrations of HQ (Figure 5c). These results indicated that,
within the HQ concentration range examined, the apoptotic effect
of HQ on YS-HSC was significantly larger than on BM-HSC.
Induction of p53 protein by HQ
The p53 protein plays an important role in apoptosis and the
protein is induced in apoptotic cells. To further verify the
apoptotic effect of HQ, p53 protein expression was measured by
immunoblotting after the cells were treated with increasing
concentrations of HQ. Figure 6 showed that the p53 protein
levels increased significantly after 24 h of incubation with HQ in
concentration-dependent manners in both YS-HSC and BM-
HSC. However, the basal level of p53 was much lower in YS-HSC
than in BM-HSC and induction by HQ was significantly more
apparent in YS-HSC and BM-HSC. The reason why the basal
level of p53 in BM-HSC was higher than that of YS-HSC is
unclear at the present.
Induction of Cyp4f18 in murine YS-HSC and BM-HSC
The murine Cyp4f18 gene is an ortholog of the human CYP4F3
gene that is induced by benzene metabolites in human blood cells.
To examine the effect of HQ on gene expression in HSC cells, the
mRNA levels of Cyp4f18 were determined by quantitative real–
time PCR in BM-HSC and YS-HSC. As shown in Figure 7a, HQ
induced the expression of Cyp4f18 mRNA expression in a
concentration-dependent manner in YS-HSC. Induction was seen
at 2.5 mM and was highest at 10 mM (,3-fold). In BM-HSC,
Induction was dramatically higher in cells treated with 2.5 mM of
HQ (.6-fold, compared with control, Figure 7b). However,
induction was decreased in higher concentrations of HQ.
Therefore, induction of Cyp4f18 mRNA by HQ exhibited
different concentration-dependence characteristics in YS-HSC
and BM-HSC. The expression and induction of Cyp4F18 proteins
in YS-HSC and BM-HSC were examined by immunoblotting.
Figure 1. Identification of YS-HSCs. (a, b, and c) Immunohisto-
chemistry staining of CD41 in E9 murine embyo yolk sacs. The arrows
refer to cells expressing CD41 in E9 murine embryo yolk sacs.
Magnifications: (a) 2006; (b) 4006; and (c) A representative section of
H & E staining of the E9 murine embryo yolk sacs (magnification of
2006).
doi:10.1371/journal.pone.0071153.g001
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Both YS-HSC (Figure 8a) and BM-HSC (Figure 8b) showed large
inductions of the Cyp4F18 protein by HQ.
Induction of DNA-PKcs and DNA double strand break in
BM-HSC
Benzene and its metabolites affect the expression of DNA-PKcs
and DNA double strand break repair as indicated by induction of
c-H2AX foci formation in blood cells. Therefore, we measured the
effect of HQ on DNA-PKcs expression and c-H2Ax formation in
the HSC cells. DNA-PKcs gene expression levels exhibited no
statistically significant differences among control and all HQ
treated groups in YS-HSC (Figure 9a). On the other hand, DNA-
PKcs mRNA levels were significantly higher in BM-HSC cells
treated with HQ at 2.5 and 5 mM (Figure 9b).
The finding that HQ induced DNA-PKcs in BM-HSC
prompted us to examine whether HQ induces DNA double
strand break repair in BM-HSC. Formation of c-H2AX foci is
characteristic of DNA double strand break repair in cells.
Figure 2. Immunophenotyping of CD117+ yolk sac cells. Representative flow cytometric data from more than three independent analyses
were shown. The cells were fluorescently stained with CD117-PE. To show the CD117+ cell purity, CD117+ yolk sac cells before separation were shown
on the left panel; CD117+ yolk sac cells after separation by using the anti-murine CD117 antibodies conjugated to mini-magnetic beads were shown
on the right panel.
doi:10.1371/journal.pone.0071153.g002
Figure 3. Effect of HQ on CFU of YS-HSC and BM-HSC after 7 days of culture in vitro. Five thousand cells were sorted directly into the
methylcellulose medium containing 0, 1.25, 2.5, or 5.0 mM hydroquinone supplemented with SCF, IL-3, IL-6, and Epo. Colony numbers were counted
on day 7. Each experiment was done in triplicates. Quantitative data represents the average number of colonies per dish. (a) Morphology of CFU-E/
BFU-E of BM-HSC and YS-HSC after 7d culture. (b) Morphology of CFU-GM of BM-HSC and YS-HSC after 7d culture. (c) CFU numbers of BM-HSC and
YS-HSC. (d) Comparison of total CFU as percent of control between BM-HSC and YS-HSC. (e) Comparison of total CFU as percent of control between
BM-HSC and YS-HSC treated with HQ at 1.25 mM. Data represent means 6 SDs of three or more separate experiments (*, P,0.05; **, P,0.01; and #,
P,0.001). CFU-GM includes CFU-granulocyte (CFU-G), CFU-macrophage (CFU-M), and CFU-granulocyte macrophage (CFU-GM). CFU-E represents
colony-forming unit-erythroid. BFU-E represents burst-forming unit-erythroid.
doi:10.1371/journal.pone.0071153.g003
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Exposure of BM-HSC cells to HQ for 6 h led to concentration-
dependent formation of c-H2AX foci (Fig. 10).
Discussion
The present study was designed to compare the toxicities of the
benzene metabolite hydroquinone on hematopoietic stem cells
derived from murine adult bone marrow and embryonic yolk sac
in order to explore a potential role of benzene and metabolites in
the development of childhood leukemia. The experiment was
based on the assumption that, in children with leukemia,
oncogenic lesions of the hematopoietic system began to appear
during the fetal development and were accumulated as a
continuation of the pregnancy, which ultimately results in the
development of leukemia after birth. Benzene and metabolites
may induce a number of chromosomal aberrations including
mitotic recombination, DNA strand breaks, chromosomal trans-
locations, and aneuploidy in hematopoietic stem or progenitor
cells. These lesions would disrupt the normal process of self-
renewal, proliferation and differentiation of HSC, but confers
HSC with an unlimited proliferative capacity, consequently
causing the arise of AML leukemia stem cells (or leukemic clones)
and leukemogenesis [4,35–39]. Thus, the study on the toxic effects
of benzene exposure on adult and embryonic hematopoietic stem
cells may reveal new mechanistic aspects of the pathogenesis of
leukemia, especially childhood leukemia.
It has been demonstrated that YS-HSC have lymphoid, myeloid
and erythroid precusor potentials [40–42]. By following the
emergence of hematopoietic stem cells in murine yolk sac [43,44],
a dominant YS-HSC in day 8.5–9.5 embryos was isolated as the
main source of embryonic hematopoietic stem cells. Currently, the
general method for isolation and purification of HSC was based on
the specific antigen markers on the cell surface. Isolation of
hematopoietic stem cells derived from bone marrow of adult mice
with the KSL (C-kit, Sca-1, lineage) phenotype is widely used in
the purification of murine HSC. However, for embryonic
hematopoietic stem cell sorting, there is no generally accepted
sorting method available. Compared to other hematopoietic stem
cells such as those derived from fetal liver and bone marrow, the
murine yolk sac hematopoietic stem cells express no stem cell
antigen (Sca-1), but express c-kit (CD117), the receptor of Throm-
bopoietin (TPO) [44–47]. Given the stability and specificity of cell
surface antigen expression, c-kit and lineage were used as the
sorting markers for YS-HSC isolation.
Figure 4. Comparison of cytotoxicities of HQ on BM-HSC and YS-HSC. Cells were exposed to increasing concentrations of HQ after 24 h
liquid culture. (a) Cell viability was measured by the trypan blue exclusion assay. The initial cell amount used was 16105/ml. Relative cell viability was
represented as the percentage of viability of treated group over the control. (b) Cell viability was determined by the CCK-8 assay. Left: Viability of BM-
HSC and YS-HSC; right: Relative viability of BM-HSC and YS-HSC over control. Data represent means 6 SDs (n = 3).
doi:10.1371/journal.pone.0071153.g004
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The colony-forming cell (CFC) assays are generally used to
quantify multi-potential progenitor and restricted progenitor cells.
Under an optimal condition, immature progenitors develop into
larger colonies containing cells of two or more lineages, whereas
mature progenitors develop into colonies containing cells of only a
single lineage. The CFC assays have become the benchmark
functional characterization to assess the ability of various
hematopoietic cell types to divide and differentiate since its
introduction over four decades ago [48]. It is also used as an
alternative method to animal models for the evaluation of the
Figure 5. Comparison of apoptotic effects of HQ on BM-HSC and YS-HSC. Cells were exposed to various concentrations of HQ after 24 h
liquid culture and were stained with Annexin V and PI. Apoptosis was determined using flow cytometry as described in Materials and Methods.
Illustrated is a representative of three separate experiments. (a) Percent of total apoptotic cells of YS-HSC. (b) Percent of total apoptotic cells of BM-
HSC. (**P,0.01, compared to control group values). (c) A representative flow cytometry data showing apoptotic effects of HQ on BM-HSC and YS-HSC
at the 5 mM concentration.
doi:10.1371/journal.pone.0071153.g005
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efficacy or lineage-specific toxicity of drugs and environmental
chemicals on human and animal hematopoietic cells [49]. Studies
have found that benzene exposure suppresses hematopoietic
progenitor cell differentiation of multilineage colony forming unit
(CFU-GEMM), colony forming unit (CFU-GM) and blast forming
unit (BFUE/CFUE) in mice [50]. Hydroquinone exposure results
in lineage-specific toxicities in both bone marrow and yolk sac
hematopoietic stem cells by the CFC assay. At the concentration
of 1.25 mM, hydroquinone caused more toxic effects on YS-HSC
than that of BM-HSC, suggesting that the progenitor differenti-
ation and proliferation of embryonic hematopoietic stem cells are
more likely to be affected by hydroquinone than adult hemato-
poietic stem cells.
During HSC self-renewal, mature progenitor cells may arise
from HSC in culture. Such mature cells may not be easily
distinguished from HSC, but the existence of the cells may
complicate the toxic effect of hydroquinone on the proliferative
capability of HSC because mature cells are less proliferative. The
CCK-8 assay was designed to determine the number of viable
primitive cells in the cell proliferation and cytotoxicity assays
without being affected by the presence of mature progenitor cells.
Our study revealed that both the cytotoxicity and the apoptosis-
Figure 6. Induction of p53 by HQ. YS-HSC (a) and BM-HSC (b) were treated with increasing concentrations of HQ for 24 h. Total cell lysates were
analyzed by immunoblotting with antibodies against p53. Expression of the GAPDH protein was used as a loading control. Upper panels:
representative blotting results. Densitometry of the immunoblotting results was shown in the lower panels. Values are presented as means 6 SDs
(n = 3–5). * P,0.05.
doi:10.1371/journal.pone.0071153.g006
Figure 7. Effect of HQ on Cyp4f18 mRNA expression. Expression of Cyp4f18 mRNA in YS-HSC (a) and BM-HSC (b) was measured by quantitative
real–time PCR. The relative expression of target genes was calculated using the 22DDCt method. Data represent means 6 SDs of at least three
individual experiments (*, P,0.05; **, P,0.01; and #, P,0.001; compared to control group values.).
doi:10.1371/journal.pone.0071153.g007
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inducing effect of HQ on YS-HSC were more noticeable than on
BM-HSC. The findings support the notion that cumulative toxic
effect is likely to occur in embryonic hematopoietic stem cells,
which leads to damage on the embryonic hematopoietic system.
We have previously reported that CYP4F3A and DNA-PKcs
mRNAs were elevated in workers diagnosed with benzene
poisoning. We also found that CYP4F3A and DNA-PKcs were
induced by benzene metabolites hydroquinone and phenol in HL-
60 and K562 cells at both mRNA and protein levels. Expression of
CYP4F3A siRNA was also found to inhibit HL-60 cell prolifer-
ation [24–26]. The murine Cyp4F18 is a functional ortholog of the
human Cyp4F3A and it is the main regulatory protein in LTB4
metabolism in murine polymorphonuclear leukocytes. Cyp4F18
deactivates LTB-4 and, thereby, contributes to suppression of
inflammation [28]. Whether Cyp4f18 can be induced by benzene
and metabolites in murine hematopoietic stem cells has not been
investigated. We observed a greater than 6-fold increase in the
mRNA levels by HQ in BM-HSC, whereas a smaller than 3-fold
induction of this gene was observed in YS-HSC (Fig. 7a, b).
Induction of Cyp4f18 inhibits the recruitment of neutrophils,
eosinophils and CD4+ effector T-cells into tissues during
inflammation [51].
The DNA-PKcs, together with the Ku70/Ku80 heterodimer
forms the biologically active DNA-PK complex that plays a key
Figure 8. Effects of HQ on Cyp4F18 protein expression. Immunoblot analysis of Cyp4f18 proteins on HQ-treated YS-HSC (a) and BM-HSC (b)
cells. Immunoblotting of Cyp4F18 was shown in the upper panels. GAPDH was measured as loading control. Densitometry of immunoblot results was
shown in the lower panels. Values are presented as means 6 SDs (n = 3–5). *, P,0.05; **P,0.01; compared with controls.
doi:10.1371/journal.pone.0071153.g008
Figure 9. Effect of hydroquinone on DNA-PKcs mRNA expression. YS-HSC (a) and BM-HSC (b) cells were treated with HQ at increasing
concentrations and expression of DNA-PKcs mRNA was measured by quantitative real–time PCR. The relative expression of target genes was
calculated using the 22DDCt method. Data represent means 6 SDs of at least three individual experiments (*, P,0.05; **, P,0.01; and #, P,0.001;
compared to control group values.).
doi:10.1371/journal.pone.0071153.g009
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role in the repair of DNA double-strand breaks through the non-
homologous end-joining (NHEJ) pathway. We found that DNA-
PKcs can be induced by HQ in BM-HSC but not in YS-HSC,
suggesting that the nonhomologous end-joining pathway was not
induced in YS-HSC. Benzene and metabolites can cause DNA
strand breaks and if the DNA damage is not repaired properly,
chromosome translocations and aneuploidy would occur [4]. The
findings suggest, but do not prove, that, upon exposure to benzene,
embryonic hematopoietic stem cells may not be able to effectively
activate the defense system to defend against the toxicity of
benzene metabolites in comparison with adult bone marrow
hematopoietic stem cells and, therefore, are more likely to have
gene-duplicating mutations and chromosome-specific transloca-
tions giving rise to leukemic clones. Further studies are needed to
determine the role of Cyp4F18 and DNA-PKcs in these
hematopoietic stem cells response to HQ toxicity as well as to
further elucidate mechanisms responsible for the differential toxic
responses to HQ in the two HSC populations.
We demonstrated that the benzene metabolite hydroquinone
causes toxicity in two kinds of hematopoietic stem cells in mice.
We compared the toxic responses to HQ between YS-HSC and
BM-HSC from the aspects of cell proliferation, differentiation and
apoptosis. Quantification of mRNA levels of Cyp4f18 and DNA-
PKcs by quantitative real-time-PCR revealed the differential
expressions of the two benzene-induced genes in YS-HSC and
BM-HSC in response to hydroquinone. Our studies on the
benzene metabolite-induced toxicity in the embryonic hemato-
poietic stem cells may be useful in understanding the pathogenesis
of childhood leukemia. Our research provides a new experimental
system for the assessment of the hematopoietic toxicity or
embryotoxicity of environmental and therapeutic agents that
potentially cause hematotoxicity or leukemia in children.
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